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ABSTRACT 
Objective: The serial passage of dengue viruses in primary dog 
kidney (PDK) cells has resulted in selection of attenuated 
viruses, However, the molecular changes responsible for loss 
of virulence are not well characterized. This article describes the 
isolation and biologic attributes of one dengue 2 virulent strain 
as a first step to allow the study of determinants of virulence 
at the molecular level. 
Methods: A15 dengue 2 Cuban strain was isolated from the 
viremic plasma of a patient with uncomplicated dengue fever 
during the 1981 epidemic. This was then subjected to serial 
passage in PDK cells. Viruses resulting from several PDK pas- 
sages were compared to the parent strain for plaque size and 
temperature sensitivity, neurovirulence in newborn mice, and 
cytopathogenic effects on LLC-MK, and C6/36-HT cell lines. 
Results: Al5 dengue 2 Cuban strain was successfully propa- 
gated in PDK cells. Primary dog kidney 52 to 53 viruses exhib- 
ited several biologic attributes, such as small plaques, 
temperature sensitivity, reduced mouse neurovirulence, and 
cytopathic effect in permissive cell lines. 
Conclusions: These results represent the first step to allow 
attenuation of this strain of dengue 2 virus. 
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Demographic and societal changes decreasing resources 
for vector-borne infectious disease prevention and con- 
trol, and changes in public health policy have all con- 
tributed to increased epidemic dengue activity, the 
development of hyperendemicity, and the emergence of 
dengue fever (DF) and dengue hemorrhagic fever (DHF) 
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epidemics. Theoretically, prevention could be achieved 
either through vector control or through immunization.’ 
Vector control is the only preventive method available 
at present, but it is expensive, has only a temporary ben- 
efit, and has been ineffective in controlling disease when 
not maintained. Prevention through vaccination is an 
important objective; however, in spite of multiple studies, 
no effective vaccine is available, and more basic studies 
are needed.’ 
Early attempts to develop dengue vaccines focused 
on the attenuation of the virus by passage in mice and 
cell cultures. Specifically, the serial passage of dengue 1, 
2, and 4 in primary dog kidney (PDK) cells has resulted 
in selection of attenuated viruses.“” This approach has 
produced a number of dengue virus strains that have var- 
ious degrees of reduced virulence for humans compared 
to the parent virus strains from which they were derived. 
The nucleotide sequence of parent dengue 2 virus with 
an attenuated strain derived by 53 serial passages in PDK 
cells revealed 53 nucleotide changes resulting in 
27 amino acid alterations scattered throughout the 
genome.’ However, because it is not easy to determine 
which changes are actually responsible for loss of viru- 
lence and which may be unimportant, it would be use- 
ful to compare the sequences of different strains at 
different PDK passage levels.’ 
One of the most serious DHF/dengue shock syn- 
drome (DSS) epidemics occurred in Cuba in 1981, where 
a dengue 2 strain caused an outbreak resulting in 344,203 
DF and DHF cases. Of these, 10,3 12 were classified as 
severe and very severe. There were 158 fatalities (101 in 
children) in only 4 months.8 Twenty-two dengue 2 iso- 
lates were obtained from DF and DHF cases.“The 
genomic study of four of these showed them to be sim- 
ilar to those from southeast Asia and specifically the New 
Guinea C and 16681 dengue 2 strains.“‘-‘* 
To investigate virulence markers at the molecular 
level, the Al5 dengue 2 Cuban strain was serially pas- 
saged in PDK cells. This article describes the isolation 
and biologic attributes of the Al5 passages in PDK cells 
as a first step to allow further study of the determinants 
of virulence at the nucleotide and amino acid levels. 
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MATERIALS AND METHODS 
Virus Strain 
A15 dengue 2 Cuban strain was obtained from the 
viremic plasma of a patient with uncomplicated DF con- 
tracted during the 1981 epidemic.13 The strain had been 
passaged four times in suckling mouse brain before pas- 
sage in PDK cells. This strain constituted the parent virus. 
A 10% suspension in phosphate buffered saline (PBS) was 
used as starting material for inoculation of tissue culture 
for attenuation studies. For serial passages, 0.5 mL of undi- 
luted virus from the previous passage was inoculated in 
PDK cells grown in 25-cm2 plastic bottles with a con- 
fluent monolayer. After 1 hour of adsorption at 37°C sup- 
plemented medium was added and cultures were 
incubated at 33°C for 7 days. The serial passage and the 
propagation of seed viruses were done under Good Lab- 
oratory Practices conditions. lja 
Cell Cultures 
The source of PDK cells was frozen primary beagle kid- 
ney cells from a colony raised and maintained under spe- 
cific pathogen-free conditions, obtained from CEMPALAB, 
Cuba. Individual ampules were thawed when needed and 
grown and maintained in Dulbecco medium with 10% 
heat-inactivated fetal bovine serum (HFBS). One lot of 
cells derived from the kidneys of four dogs was used 
throughout the study. I4 
Aedes albopictw (C6/36-HI) and LLC-MK, (CCL-7; 
American type collection) cell cultures were grown in 
Eagle’s minimal medium supplemented with HFBS, 1% 
nonessential amino acids, and 1% 200 mM glutamine solu- 
tion. Maintenance medium was identical to the growth 
medium but supplemented with 2% of HFBS. Cells grown 
in plastic tubes, were inoculated at two multiplicities of 
infection (ml = 0.01 and m, = 0.0001) with parent and 
PDK 20, 40, 52 to 55 viruses. Following adsorption for 
30 minutes, 1 mL of supplemented medium was added. 
Cells were kept at 33” and 37°C respectively (depending 
on the cell culture), and observed daily for viral cyto- 
pathic effect (CPE). 
Virus Assays 
Tttrations 
Viral plaque assay to test the infectivity of viral passages, 
to identify the plaque size, and to identify temperature 
sensitivity were performed in baby hamster kidney (BHK- 
21, clone 15) cell line, as previously described.15 Briefly, 
virus dilution (50 p,L) was added to 0.5 mL of BHK-21 
suspension (1.5 X lo5 cells) in each of three wells of a 
24-well polystyrene plate. After 4 hours of incubation at 
37°C in 5% CO,, each well received 0.5 mL of 3% medium- 
viscosity carboxymethyl cellulose, made up Earle’s mini- 
mum essential medium with 10% heat-inactivated fetal 
bovine serum. Plates were incubated for 5 days in the 
same conditions as above. The medium was discarded by 
inverting plates. The plates were then rinsed gently under 
tap water, fured, and stained using a solution of naphtol 
blue-black and acetic acid. For temperature sensitivity stud- 
ies, inoculated cells were incubated both at 37°C and at 
39.2”C. Each experiment was repeated at least twice. 
Immunofluorescence 
An indirect immunofluorescence test was used to detect 
virus antigen in inoculated PDK cells using dengue 2-spe- 
cific monoclonal antibody donated by Dr. D. Gubler from 
Centers for Disease Control and Prevention (Atlanta, Geor- 
gia, USA). 
Animal Inoculation 
One- to 2-day-old suckling mice were inoculated intra- 
cerebrally with 0.02-mL volumes of diluted viruses. The 
mice were observed for sickness and death for 21 days. 
For the purposes of this calculation, mice surviving over 
2 1 days were scored as dying on day 2 1. The mouse 50 
lethal dose (LD50) endpoints were determined by the 
Reed-Muench method.lb Deaths observed in the first 24 
to 48 hours were not considered. 
Statistical Analysis 
Student’s t-test, Spearman correlation, and variance analy- 
sis were used. 
RESULTS 
Sixty serial passages were obtained from Al5 dengue 2 
Cuban strain on PDK cells. At different passage levels in 
PDK cells, approximately 15 mL of virus seed was pre- 
pared. Characteristics of the selectants are shown in 
Tables 1 to 4. 
Immunofluorescence was positive in all tested viral 
passages, allowing the study of viral replication. 
Moderate growth (circa 102-lo3 plaque-forming units 
(PFU)/mL) occurred with all PDK viruses. Parent virus 
Table 1. Viral Plaque Size of Some Passages 
PDK 
Plaque Size (mm) 
Passage Level Mean Standard Deviation 
4* (parent virus) 1.520 0.394 
20 1.780 0.280 
40 1.660 0.210 
52 1.529 0.400 
53 1.164 0.401 
54 0.856 0.246 
55 1.032 0.384 
P < 0.01; *4 passages in suckling mouse brain. 
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Table 2. Effect of Temperature on Viral Infectivity of Some Passages 
PDK Passage Level 37°C 39.2"C PFU 39.2W37”C 
4* (parent virus) 2.10 x 105 0.86 x 102 0.400 
20 2.40 X IO3 1.00 x 10 0.410 
40 3.40 x 103 1.20 x 103 0.431 
52 1.16 x lo3 0.13 x 10 0.110 
53 6.60 x 102 0.98 x 10 0.140 
54 7.60 X 10" 1.30 x 10 0.170 
55 1.16 x lo3 0.13 x 10 0.110 
P < 0.01; PFU = plaque-forming units; *4 passages in suckling mouse brain. 
Reduction Percentage 
60.0 
59.0 
64.7 
89.0 
86.0 
83.0 
89.0 
showed the highest titer (lo5 PFU/mL) and PDK 53 to 54 
the lowest (lo* PFU/mL). Stability of viral titers was 
observed. 
Plaque size diminished from 1.5 mm in the parent 
virus to between 0.8 and 1.1 mm at PDK 53 to 55 viruses 
(P < 0.01). After PDK 55 virus passage, an increase in the 
plaque size was observed (data not shown). Table 1 
shows the means and standard deviations of plaque size 
at different passages. 
Viral infectivity of some PDK passages was compared 
with the parent virus grown at 37°C and 39.2”C (see 
Table 2). A gradual decrease of infectivity was observed 
at PDK 52 to 55 (r = -0.75; P < 0.01). The parent virus 
showed some restriction of growth at 39.2”C. In a sepa- 
rate test, 40°C was found to be nonpermissive for plaque 
formation by the parent virus. 
Primary dog kidney cultures inoculated with serially 
passaged viruses were observed daily for CPE; PDK 53 
to 55 viruses showed almost no CPE in LLC-MK, and 
C6/3GHT cell lines at both multiplicities tested, being 
more evident at the lowest. Parental virus produced com- 
plete CPE in 4 to 5 days. 
An increase in PDK passage level resulted in a grad- 
ual lengthening of the mean interval to the day of death 
after intracerebral inoculation into suckling mice (see 
Table 3). Also, PDK 52 and 55 showed a 90 to 97% reduc- 
tion of neurovirulence (r = -0.78; P < 0.05). 
Table 4 shows a summary of biologic properties of 
dengue 2 (A15) at different passage levels in PDK cell 
culture. 
DISCUSSION 
Conventional techniques for attenuation of viruses, such 
as passage of virus at low temperature or passage in het- 
erologous tissues continues to have a role in the devel- 
opment of live-virus vaccines.” In the particular case of 
dengue, propagation in tissue culture has yielded viruses 
that have been demonstrated to have attenuated viru- 
lence in humans.‘8-2” Differential propagation has also 
been shown to affect the tropism of dengue viruses for 
various cell lines in vitro, temperature sensitivity, plaque 
size, cytopathic effects in vitro, and mouse neuroviru- 
lence.*r These biologic markers have been reported as 
important for viral attenuation; however, owing to the 
lack of a good animal model for dengue infection, the 
distinction between nonattenuated and attenuated viruses 
must be determined empirically, using these biologic 
markers.** 
The development of DHF has been related to more 
virulent strains, however, until now only nonspecific 
nucleotide or amino acid changes have been deter- 
mined.2”-25 It is possible that if a more virulent strain 
could be attenuated, it would be possible to identify and 
characterize the factors influencing virulence and, as a 
consequence, enhanced immunogenic&y. 
In agreement with observations made by other 
authors,4-6 serial passage of the Al5 dengue 2 Cuban 
strain in PDK cells, resulted in several stable changes, 
such as temperature of restricted replication, small plaque 
size, extension of survival in suckling mice, and reduced 
Table 3. Suckling Mouse Neurovirulence of Some Passages 
PDK Passage Level 37°C LD50 LD5O/PFU37”C 
4* (parent virus) 2.1 x 105 1046' 0.190 
20 1.1 x 103 102.74 0.490 
40 3.4 x 103 lOSO 0.290 
52 1.2 x 103 102O8 0.091 
53 1.0 x 103 lo'g' 0.105 
54 3.2 X lo* 102'3 0.220 
55 1.9 x 103 10'85 0.030 
P < 0.05: PFU = plaque-forming units: *4 passages in suckling mouse brain, 
Reduction Percentage 
81.0 
51 .o 
71.0 
90.9 
89.5 
78.0 
97.0 
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Table 4. Summary of Biologic Properties of Cuban Dengue 2 Virus at Different Passage Levels in Primary Dog Kidney Cell Culture 
PDK Passage Levels 
EGologic Parameter Parent 20 40 52 53 54 55 
Temperature sensitivity at 39.2% - - + + + + 
PDk plaque size (mmj 1.5 1.5 1.4 1.5 1 .l 0.8 1 
LLC-MK, CPE + + + - - - - 
C6/36-HT CPE 
Suckling mouse neurovirulence reduction percentage EA 5’1 7’1 
- - 
90 a9 78 97 
CPE = cytopathic effect. 
cytopathic effect in two permissive cell lines. These bio- 
logic markers have been used to evaluate changes in bio- 
logic properties that may be suitable for empirical 
assessment. A decrease in viral titer was also observed, 
probably demonstrating the nonpermissive action of PDK 
cells to dengue virus. These findings are consistent with 
previous observations and suggest that the biologic attrib- 
utes of the Cuban strain were changed during PDK 53 to 
55 passages. 
Recently, molecular characterization of dengue virus 
attenuation was attempted by comparison of sequences 
of the parental virus and a derived vaccine strain pre- 
pared by serial passage in PDK cellsz6 The degree of 
attenuation appeared to increase with PDK passage level, 
and multiple mutations probably contributed to this high 
level of attenuation. In this study, multiple nucleotide 
changes in various regions of the dengue virus genome, 
some of which resulted in amino acid changes, have been 
found in the vaccine strain. It remains to be defined 
which mutations are responsible for attenuation and 
which are not.27 In another study, the authors demon- 
strated profound changes, including decreased growth in 
LLC-MK, and C6/36-HT cells, of deletions engineered into 
the 5’ NC region of dengue 4 virus variants.” 
The comparison of other viruses, of different tem- 
poral and geographic origins but with the same cell his- 
tory of passage could allow the definition of which 
nucleotide and amino acid changes are persistent. These 
results are important in relation to the attenuation 
process and, consequently, vaccine development. They 
will be used in molecular comparison studies of Al5 
Cuban attenuated strain with the parent virus. 
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